1、 FOR IMMEDIATE RELEASECardinal Health Reports First Quarter Fiscal 2023 ResultsRevenue increased 13%to$49.6 billionGAAP1 operating earnings were$137 million,GAAP diluted EPS were$0.40Non-GAAP operating earnings decreased 20%to$423 million due to a decline in Medical segment profit,partially offset b

2、y an increase in Pharmaceutical segment profit;non-GAAP diluted EPS decreased 7%to$1.20Company reaffirmed fiscal year 2023 non-GAAP EPS guidanceDUBLIN,Ohio,November 4,2022-Cardinal Health(NYSE:CAH)today reported first quarter fiscal year 2023 revenues of$49.6 billion,an increase of 13%from the first

3、 quarter of last year.First quarter GAAP operating earnings were$137 million,including a non-cash,pre-tax goodwill impairment charge of$154 million in the Medical segment.GAAP diluted earnings per share(EPS)were$0.40.Non-GAAP operating earnings decreased 20%to$423 million in the quarter due to a dec

4、line in Medical segment profit,primarily resulting from net inflationary impacts,partially offset by an increase in Pharmaceutical segment profit.Non-GAAP diluted earnings per share decreased 7%to$1.20,reflecting the change in non-GAAP operating earnings,partially offset by lower interest expense an

5、d a lower non-GAAP effective tax rate and share count.“Our performance in the first quarter demonstrated stable fundamentals in the Pharmaceutical segment and tangible progress in the Medical segment,”said Jason Hollar,CEO of Cardinal Health.“We are reaffirming our full year non-GAAP EPS guidance as

6、 we remain focused on our Medical Improvement Plan initiatives and building upon the growth of our Pharmaceutical business.Across the company,we are operating with urgency to drive our businesses forward and remain committed to creating shareholder value.Q1 FY23 summaryQ1 FY23Q1 FY22Y/YRevenue$49.6